Aarti Drugs Limited Announces Major Leadership Changes; Rashesh C. Gogri Elevated to Chairman, Adhish P. Patil Appointed Managing Director

Aarti Drugs Limited Announces Major Leadership Changes; Rashesh C. Gogri Elevated to Chairman, Adhish P. Patil Appointed Managing Director​

Aarti Drugs Limited has announced significant changes in its board composition following a meeting held on July 31, 2026. The company confirmed the retirement of Shri Prakash M. Patil and outlined new appointments for key executive roles, including the elevation of Shri Rashesh C. Gogri as Chairman and the appointment of Shri Adhish P. Patil as Managing Director.

The Board accepted the resignation of Shri Prakash M. Patil, who has served as Chairman, Managing Director, and Chief Executive Officer (CEO) since 2014. His retirement is effective from September 30, 2026. Shri Prakash M. Patil expressed his desire for early retirement, citing a belief that it was an appropriate time for an orderly leadership transition, despite his scheduled term expiring on May 31, 2027. The Board acknowledged his invaluable contribution and long association with the company since inception.

New Leadership Appointments​

The Board approved the following key appointments to ensure a smooth leadership transition:

• Shri Rashesh C. Gogri: Shri Rashesh C. Gogri, who has been associated with Aarti Drugs Limited as Managing Director since September 2014, was elevated by the Board to the position of Chairman of the Company, effective from October 1, 2026.
• Shri Adhish P. Patil: Shri Adhish P. Patil, who has served as Chief Financial Officer (CFO) since April 2014, was appointed as Managing Director with effect from October 1, 2026 for a period of five years. His appointment is subject to approval by the shareholders in an ensuing Annual General Meeting.

Director Appointments and Reappointments​

The company also approved several changes regarding its executive and independent directors, pending shareholder approval:

• Shri Nilesh B. Patil: Shri Nilesh B. Patil (DIN: 08616943) was appointed as a Whole-time Director for a period of five years, effective from the conclusion of the ensuing Annual General Meeting, replacing Shri Uday M. Patil, who has served the company for over 25 years and has not sought re-appointment.
• Shri Harshit M. Savla: Shri Harshit M. Savla (DIN: 00005340) was reappointed as Joint Managing Director for a further period of five years, effective from June 1, 2027.
• Reappointments: The Board also approved the second term appointments for Independent Directors Shri Harit P. Shah and Shri Hasmukh B. Dedhia (effective March 29, 2027), as well as independent directors Shri Ajit E. Venugopalan and Shri Sandeep M. Joshi (effective March 29, 2027).

Board Committee Reconstitution​

In light of these appointments and cessations, the Board approved the reconstitution of several committees effective from October 1, 2026:

Audit Committee
The committee includes Shri Hasmukh B. Dedhia (Independent Director, Chairman), along with independent directors Smt Neha R. Gada and Shri Ajit E. Venugopalan, and Managing Directors Shri Rashesh C. Gogri and Shri Adhish P. Patil.

Nomination and Remuneration Committee
Smt Neha R. Gada (Independent Director, Chairperson) chairs the committee, which includes independent directors Shri Ankit V. Paleja and Bhaskar N. Thorat, alongside Managing Director Shri Rashesh C. Gogri.

Risk Management Committee
Shri Rashesh C. Gogri serves as the Chairman of the Risk Management Committee. Members include Managing Director Shri Adhish P. Patil, Jt. Managing Director Shri Harshit M. Savla, and Executive Director Shri Harit P. Shah.

Corporate Social Responsibility (CSR) Committee
The CSR committee is chaired by Independent Director Bhaskar N. Thorat and includes Managing Directors Shri Adhish P. Patil and Shri Rashesh C. Gogri.

Finance and Investment Committee
Shri Rashesh C. Gogri is the Chairman of the Finance and Investment Committee, with members including Managing Director Shri Adhish P. Patil, Jt. Managing Director Shri Harshit M. Savla, and Executive Director Shri Harit P. Shah.

AARTIDRUGS Stock Price Movement​

On Friday, shares of Aarti Drugs Limited edged higher, settling at ₹422.75 after gaining 2.47%. The stock traded a volume of 187,361 shares during the session, trading within a range established by a low of ₹412.00 and a high of ₹427.20.